Here is the program outline (as of Jan 29, 2024) for the 15th Annual Meeting!

Here is the program outline (as of Jan 29, 2024) for the 15th Annual Meeting!

2024

9:20〜9:50 Registration and Poster Display
9:50~10:00 President's Welcome and Information
Taeko Kubo (Sumitomo Pharma Co., Ltd.) and Takeshi Arai (Drug Safety Testing Center Co., Ltd.)
10:00 〜 10:45 Special Lecture::Reverse Translational Studies (Vomiting and Gastrointestinal Discomfort) Establishment of quantitative evaluation technique for nausea and malaise in laboratory animals
Kouichi Yamamoto(Department of Radiological Sciences, Faculty of Medical Science Technology, Morinomiya University of Medical Sciences)

Co-Chairs: Masaki Honda (Chugai Pharmaceutical Co., Ltd.) and Tomohiko Taniguchi (Eisai Co., Ltd.)
10:50 ~ 11:20 Exhibition Booth: Flash Talk
Moderators: Takeshi Ishii (Drug safety testing Center, Inc.)
11:20 ~ 11:50 Exhibition
11:50 ~ 12:50 Luncheon Seminars 1 (Sponsored by Certara G.K. and Eurofins Discovery)
  1. Secondary Intelligence™:The smart way to evaluate off-target pharmacology quantitatively and consistently
    Will Redfern (Vice President, Quantitative Systems Toxicology and Safety, Certara UK)
    Moderator: Noriko Okudaira (Certara G.K.)

  2. De-risking Strategy for CNS Safety Pharmacology
    Chun-Yao Lee (Eurofins Discovery Taiwan)
    Moderator: Makoto Imatachi (Eurofins Discovery)

12:50 ~ 13:10

Break, Poster & Exhibts

13:10 〜 14:40

Symposium (CNS): Depression (Clinical Big Data, Psychiatric disorder mechanisms)
  1. Analysis of drug-associated depression using the Food and Drug Administration Adverse Event Reporting System (FAERS)
    Mitsuhiro Nakamura (Laboratory of Drug Informatics, Gifu Pharmaceutical University)
  2. The Biological Basis of Stress and Mental Illness
    Tomoyuki Furuyashiki(Kobe University Graduate School of Medicine)

Co-Chairs: Takashi Takafumi Shirakawa (Astellas Pharma Inc.) and Tohko Arai (Shionogi & Co., Ltd.)

14:40 〜 15:00

Break, Poster & Exhibts
15:00 〜 15:55 Invited Lecture and Diplomate in Safety Pharmacology Awards
Transitioning from Animal Testing: Insights Gained and Future Directions
Marie-Luce Rosseels (SPS2023 President, UCB BioPharma SRL)<
Chair: Takashi Yoshinaga (Eisai Co., Ltd.)
14:55 〜 16:05 Break, Poster & Exhibts

16:05 〜 17:45

Workshop: future safety pharmacology (Central evaluation and AI, alternative Methods)
  1. Introduction
    Tomoharu Osada (Mediford Corporation)

  2. Prediction of drug-induced intestinal toxicity with the use of human/animal crypt-derived intestinal stem cells and differentiated cells
    Kazuya Maeda (School of Pharmacy, Kitasato University)

  3. Artificial Intelligence Technology and Brain Imaging in Psychiatry
    Hidehiko Takahashi (Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University)

Co-Chairs: Tomoharu Osada (Mediford Corporation) and AtsushiJun Fujiwara (Ina Research Inc.)

17:45 〜 18:10

Break

18:10~ 20:40

Banquet, Lecture:
History of Safety Pharmacology JSPS; The past and the future
Co-Chairs: Kohei Sawada (Director, Japanese Safety Pharmacology Society) and Kentaro Ando (Chiba Institute of Science, Faculty of Pharmacy)